Insider · CIK 0001215242
LEFF JONATHAN S
Reports to the SEC for 14 companies · BALA CYNWYD, PA
Transactions
50
Companies
14
Filings
18
CIK
0001215242
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-05-19 | LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-05-13 | LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-04-14 | HLSQTessera Defense & Homeland Security Inc. · Common Stock Options - right to BuyA Award | — |
| 2025-04-14 | HLSQTessera Defense & Homeland Security Inc. · Common Stock Options - right to BuyA Award | — |
| 2024-07-11 | HLSQTessera Defense & Homeland Security Inc. · Common Stock Options - Right to BuyA Award | — |
| 2024-05-29 | LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-05-09 | LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-05-10 | LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-05-12 | LRMRLarimar Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2020-09-29 | LRMRLarimar Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2018-06-08 | TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2017-08-02 | TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2016-02-10 | AveXis, Inc.Stock Option (Right to Buy)A Award | — |
| 2016-02-10 | AveXis, Inc.Stock Option (Right to Buy)A Award | — |
| 2015-09-11 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to Buy)A Award | — |
| 2015-07-16 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to Buy)A Award | — |
| 2013-02-28 | INTERMUNE INCF Tax Payment | −$62.5K |
| 2012-09-04 | ALLOS THERAPEUTICS INCU Disposition from Tender | −$100K |
| 2012-06-04 | INTERMUNE INCA Award | +$25.3K |
| 2012-06-04 | INTERMUNE INCStock Option (Right to Buy)A Award | — |
| 2012-02-17 | Talon Therapeutics, Inc.Stock Option (right to buy)A Award | — |
| 2012-01-09 | Talon Therapeutics, Inc.Series A-2 Convertible Preferred Stock, $0.001 Par ValueA Award | +$9.9M |
| 2012-01-09 | Talon Therapeutics, Inc.Right to acquire Series A-3 Convertible Preferred StockA Award | — |
| 2011-12-13 | ALLOS THERAPEUTICS INCA Award | — |
| 2011-06-21 | ALLOS THERAPEUTICS INCStock Options (Right to Buy)A Award | +$41.2K |
| 2011-06-07 | INTERMUNE INCJ Other | — |
| 2011-06-07 | INTERMUNE INCJ Other | — |
| 2011-05-13 | INSPIRE PHARMACEUTICALS INCU Disposition from Tender | −$115M |
| 2011-05-13 | INSPIRE PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2011-05-13 | INSPIRE PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2011-05-13 | INSPIRE PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2011-05-13 | INSPIRE PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2011-05-13 | INSPIRE PHARMACEUTICALS INCRestricted Stock UnitD Disposition to Issuer | — |
| 2011-05-11 | INTERMUNE INCJ Other | — |
| 2011-05-11 | INTERMUNE INCJ Other | — |
| 2011-05-10 | INTERMUNE INCNon-Qualified Stock Option (Right to Buy)A Award | — |
| 2011-04-01 | Talon Therapeutics, Inc.Stock Option (right to buy)A Award | — |
| 2010-10-12 | ZYMOGENETICS INCStock Option (Right to buy)D Disposition to Issuer | −$61.8K |
| 2010-10-12 | ZYMOGENETICS INCStock Option (Right to buy)D Disposition to Issuer | −$61.7K |
| 2010-10-12 | ZYMOGENETICS INCStock Option (Right to buy)D Disposition to Issuer | −$22.2K |
| 2010-10-12 | ZYMOGENETICS INCStock Option (Right to buy)D Disposition to Issuer | — |
| 2010-10-12 | ZYMOGENETICS INCStock Option (Right to buy)D Disposition to Issuer | — |
| 2010-10-12 | ZYMOGENETICS INCStock Option (Right to buy)D Disposition to Issuer | — |
| 2010-10-12 | ZYMOGENETICS INCStock Option (Right to buy)D Disposition to Issuer | — |
| 2010-10-12 | ZYMOGENETICS INCStock Option (Right to buy)D Disposition to Issuer | — |
| 2010-10-12 | ZYMOGENETICS INCStock Option (Right to buy)D Disposition to Issuer | −$30.2K |
| 2010-10-07 | ZYMOGENETICS INCU Disposition from Tender | −$91.5M |
| 2010-09-10 | Talon Therapeutics, Inc.Series A-1 Convertible Preferred Stock, $0.001 Par ValueA Award | — |
| 2010-07-30 | Talon Therapeutics, Inc.Stock Option (right to buy)A Award | — |
| 2010-06-22 | ALLOS THERAPEUTICS INCStock Options (Right to Buy)A Award | +$127K |
Recent filings
- 4LEFF JONATHAN S0001193125-26-232933SEC(opens sec.gov)
- 4LEFF JONATHAN S0001062993-25-009376SEC(opens sec.gov)
- 4/ALEFF JONATHAN S0001213900-25-033476SEC(opens sec.gov)
- 4LEFF JONATHAN S0001213900-25-033357SEC(opens sec.gov)
- 4LEFF JONATHAN S0001213900-24-061457SEC(opens sec.gov)
- 4LEFF JONATHAN S0001062993-24-011571SEC(opens sec.gov)
- 4LEFF JONATHAN S0001062993-23-010806SEC(opens sec.gov)
- 4LEFF JONATHAN S0001062993-22-012304SEC(opens sec.gov)
- 4LEFF JONATHAN S0001192482-21-000442SEC(opens sec.gov)
- 4LEFF JONATHAN S0001192482-20-000740SEC(opens sec.gov)
- 4LEFF JONATHAN S0001193805-18-000828SEC(opens sec.gov)
- 4LEFF JONATHAN S0001193805-17-001422SEC(opens sec.gov)
- 4AveXis, Inc.0001209191-16-098226SEC(opens sec.gov)
- 4Nivalis Therapeutics, Inc.0001104659-15-065277SEC(opens sec.gov)
- 4Nivalis Therapeutics, Inc.0001104659-15-051898SEC(opens sec.gov)
- 4INTERMUNE INC0001209191-13-012996SEC(opens sec.gov)
- 4ALLOS THERAPEUTICS INC0001127602-12-025801SEC(opens sec.gov)
- 4INTERMUNE INC0001209191-12-032658SEC(opens sec.gov)
Companies
- ALLOS THERAPEUTICS INCDirector
- ALPINE IMMUNE SCIENCES, INC.Director
- Altus Pharmaceuticals Inc.Director, 10% Owner
- ARS Pharmaceuticals, Inc.DirectorSPRY
- AveXis, Inc.Director
- INSPIRE PHARMACEUTICALS INCDirector
- INTERMUNE INCDirector
- Larimar Therapeutics, Inc.DirectorLRMR
- NEUROGEN CORPDirector
- Protara Therapeutics, Inc.DirectorTARA
- Talon Therapeutics, Inc.Director
- Tessera Defense & Homeland Security Inc.DirectorHLSQ
- Viracta Therapeutics, Inc.Director, 10% OwnerVIRX
- ZYMOGENETICS INCDirector, 10% Owner
Address
C/O LARIMAR THERAPEUTICS, INC. THREE BALA PLAZA EAST, SUITE 506
BALA CYNWYD, PA, 19004